Ocean Biomedical, Inc.
OCEA
$0.0061
-$0.0006-8.96%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -8.24M | 283.00K | -5.53M | -17.23M | 13.00M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 73.00K | 279.00K | -- | -- | -- |
| Total Other Non-Cash Items | 7.05M | -2.56M | 4.41M | 16.18M | -14.05M |
| Change in Net Operating Assets | 759.00K | -520.00K | 235.00K | 767.00K | 561.00K |
| Cash from Operations | -356.00K | -2.52M | -885.00K | -290.00K | -485.00K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 909.00K | 2.50M | 896.00K | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 909.00K | 2.50M | 896.00K | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 553.00K | -16.00K | 11.00K | -290.00K | -485.00K |